TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CGTX

Cognition Therapeutics Inc

Healthcare · Biotechnology

0.9365$ -1.5% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns Cognition Therapeutics Inc (CGTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 91.9% of the shares are freely tradable; institutional investors hold 24.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 24.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 91.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 8.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 95Mio.

Largest Shareholders

Institutions

Institutions CGTX
Name Stake (%) Shares Change (%) Date
BIOS CAPITAL MANAGEMENT, LP 6.31 6,000,000 +0.0 06/30/2026
Davenport & Company LLC 4.48 4,259,511 +47.2 06/30/2026
Vanguard Capital Management, LLC 3.16 3,001,787 +0.0 03/31/2026
Renaissance Technologies Corp 1.17 1,117,136 +15.2 03/31/2026
Chescapmanager LLC 1.05 997,029 +0.0 06/30/2026
BlackRock Inc 1.02 968,362 -4.5 03/31/2026
Geode Capital Management, LLC 0.97 920,208 +5.3 03/31/2026
Hilton Capital Management, LLC 0.58 548,950 +0.0 06/30/2026
Vanguard Fiduciary Trust Co 0.49 463,684 +0.0 03/31/2026

Funds

Funds CGTX
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.57 2,444,295 +0.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?